Ameritas Investment Partners, Inc. Repligen Corp Transaction History

Ameritas Investment Partners, Inc.

  • $2.98 Billion
  • Q3 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 14,886 shares of RGEN stock, worth $2.15 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
14,886
Previous 11,053 34.68%
Holding current value
$2.15 Million
Previous $1.39 Million 59.01%
% of portfolio
0.07%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$119.79 - $167.35 $459,155 - $641,452
3,833 Added 34.68%
14,886 $2.22 Million
Q2 2024

Aug 13, 2024
SELL
$120.0 - $182.95 $49,440 - $75,375
-412 Reduced 3.59%
11,053 $1.39 Million
Q4 2023

Feb 14, 2024
SELL
$114.17 - $185.35 $18,723 - $30,397
-164 Reduced 1.41%
11,465 $2.06 Million
Q3 2023

Nov 13, 2023
SELL
$138.78 - $176.51 $180,691 - $229,816
-1,302 Reduced 10.07%
11,629 $1.85 Million
Q2 2023

Aug 11, 2023
SELL
$138.42 - $180.31 $29,760 - $38,766
-215 Reduced 1.64%
12,931 $1.83 Million
Q1 2023

May 10, 2023
SELL
$154.26 - $198.1 $33,628 - $43,185
-218 Reduced 1.63%
13,146 $2.21 Million
Q4 2022

Feb 13, 2023
BUY
$162.42 - $220.56 $14,942 - $20,291
92 Added 0.69%
13,364 $2.26 Million
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $76,359 - $121,955
-476 Reduced 3.46%
13,272 $2.48 Million
Q4 2021

Feb 11, 2022
BUY
$247.59 - $304.47 $50,508 - $62,111
204 Added 1.51%
13,748 $3.64 Million
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $50,055 - $83,321
-257 Reduced 1.86%
13,544 $3.91 Million
Q2 2021

Aug 06, 2021
SELL
$165.87 - $220.95 $36,325 - $48,388
-219 Reduced 1.56%
13,801 $2.76 Million
Q1 2021

May 14, 2021
BUY
$180.37 - $226.26 $19,840 - $24,888
110 Added 0.79%
14,020 $2.73 Million
Q4 2020

Feb 12, 2021
BUY
$148.08 - $206.57 $12,882 - $17,971
87 Added 0.63%
13,910 $2.67 Million
Q3 2020

Nov 13, 2020
BUY
$122.51 - $158.27 $24,992 - $32,287
204 Added 1.5%
13,823 $2.04 Million
Q2 2020

Aug 05, 2020
SELL
$94.33 - $140.48 $381,564 - $568,241
-4,045 Reduced 22.9%
13,619 $1.68 Million
Q1 2020

May 13, 2020
BUY
$84.96 - $109.14 $2,378 - $3,055
28 Added 0.16%
17,664 $1.71 Million
Q4 2019

Feb 13, 2020
BUY
$73.84 - $93.08 $16,170 - $20,384
219 Added 1.26%
17,636 $1.63 Million
Q3 2019

Nov 14, 2019
BUY
$76.65 - $95.51 $1.02 Million - $1.28 Million
13,362 Added 329.52%
17,417 $1.34 Million
Q2 2019

Aug 14, 2019
BUY
$54.2 - $85.95 $46,341 - $73,487
855 Added 26.72%
4,055 $349,000
Q4 2017

Feb 14, 2018
BUY
$32.53 - $38.92 $9,238 - $11,053
284 Added 9.74%
3,200 $116,000
Q2 2017

Aug 15, 2017
BUY
N/A
2,916
2,916 $121,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email